The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
Status:
Completed
Trial end date:
2020-02-25
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study
designed to assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of
LC350189 and Naproxen when administered alone and in combination in healthy subjects.